ASO Positive Human Serum

<strong>ASO Positive Human Serum</strong>_x000D_ <strong>Catalog number:</strong> B2015082_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Serum_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> ASO Positive Human Serum – 3APH001_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Shimizu M, Suzuki K, Kato K, Jojima T, Iijima T, Murohisa T, Iijima M, Takekawa H, Usui I, Hiraishi H, Aso Y. Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease Diabetes Obes Metab. 2019 Feb;21(2):285-292._x000D_ 2: Ben-Chetrit E, Moses AE, Agmon-Levin N, Block C, Ben-Chetrit E. Serum levels of anti-streptolysin O antibodies: their role in evaluating rheumatic diseases Int J Rheum Dis. 2012 Feb;15(1):78-85._x000D_ 3: Shi Y, Lu A, Wang X, Belhadj Z, Wang J, Zhang Q. A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives Acta Pharm Sin B. 2021 Aug;11(8):2396-2415._x000D_ 4: Aso Y, Kimura N, Matsubara E. Novel Serum Biomarkers of Neurovascular Unit Associated with Cortical Amyloid Deposition J Alzheimers Dis. 2021;84(2):905-914._x000D_ 5: Yamaguchi Y, Aso M, Nagasawa H, Wada M. Atezolizumab-associated Dermatomyositis in Advanced Small-cell Lung Carcinoma Intern Med. 2021 Sep 15;60(18):3025-3029._x000D_ 6: Xie M, Wang J, Gong W, Xu H, Pan X, Chen Y, Ru S, Wang H, Chen X, Zhao Y, Li J, Yin Q, Xia S, Zhou X, Liu X, Shao Q. NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3 J Autoimmun. 2019 Aug;102:96-113._x000D_ 7: Bennett J, Moreland NJ, Williamson DA, Carapetis J, Crane J, Whitcombe AL, Jack S, Harwood M, Baker MG. Comparison of group A streptococcal titres in healthy children and those with pharyngitis and skin infections J Infect. 2022 Jan;84(1):24-30._x000D_ 8: Li T, Cao H, Zhuang J, Wan J, Guan M, Yu B, Li X, Zhang W. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans Clin Chim Acta. 2011 Jan 14;412(1-2):66-70._x000D_ 9: Toto M, Margari F, Simone M, Craig F, Petruzzelli MG, Tafuri S, Margari L. Antibasal Ganglia Antibodies and Antistreptolysin O in Noncomorbid ADHD J Atten Disord. 2015 Nov;19(11):965-70._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/18320067">10: Spänkuch B, Steinhauser I, Wartlick H, Kurunci-Csacsko E, Strebhardt KI, Langer K. Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles Neoplasia. 2008 Mar;10(3):223-34. </a>_x000D_ _x000D_ <strong>Products Related to ASO Positive Human Serum can be found at</strong> <a href="https://moleculardepot.com/product-category/Biofluids/"> Biofluids</a>